First-trimester medication abortion: anemia and blood loss
Communities most severely impacted by abortion restrictions and bans also experience significantly higher rates of anemia. Guidelines that restrict medication abortion to patients who meet arbitrary hemoglobin cutoffs can lead to delays and barriers to care. Studies using current medication regimens and including patients with moderate-to-severe anemia and gestational duration greater than 63 days are needed to inform eligibility and safety, and support provider buy-in and equity.
Authors
- Lucy Rose (ORCID: https://orcid.org/0000-0002-2741-3951)
- S. Putnam (ORCID: https://orcid.org/0000-0003-3532-6919)
- Eve Espey
Institutions
- University of New Mexico (US)
Publication Details
- Journal
- Current Opinion in Obstetrics & Gynecology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1097/gco.0000000000001063
- Citations
- 1
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 1.88